Aaron Siri, a lawyer advising Robert F. Kennedy Jr. as he prepared to become health secretary, petitioned the Food and Drug Administration in 2022 to revoke approval of a polio vaccine that is used widely in the U.
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering anti-smoking advocates.
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level. A single production lot of the washed and ready-to-eat Marketside Broccoli Florets by Braga Fresh were voluntarily recalled after random testing by Texas Health and Human Services in a store identified the presence of the bacteria Listeria monocytogenes.
Broccoli packages sold at Walmart stores in 20 states have received an elevated recall status over a Listeria contamination that has potentially fatal consequences.
A party bag of potato chips from Lay's was recalled in December, and has just been given the highest recall classification from the FDA.
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.
The husband of one of the passengers onboard the American Airlines plane that crashed over Washington DC yesterday evening has revealed the heartbreaking final text he received from his wife. According to the Federal Aviation
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence that GLP-1 drugs improve overall health along with weight loss.
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco harm
NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy treatment market with its Responsive Neurostimulation (RNS) System.